Our leadership team brings together cutting-edge expertise in oral biologics with proven commercial and financial leadership to unlock the full potential of advanced therapeutic solutions.
30+ years in biologics and drug delivery. Founder and executive leader advancing innovative oral biologics platforms from discovery through translational
25+ years in drug delivery and biologics development. Led multiple programs across nanoparticles, oral biologics, and IND‑enabling formulation science
35+ years leading global development programs. Directed hundreds of IND and first‑in‑human programs across multiple therapeutic modalities
Senior enterprise leader with decades of experience
scaling life‑science businesses, partnerships,
and revenue across global markets
30+ years in biotech finance and governance.
Led capital raises, M&A, and public‑market
finance for global biotech and CRO organizations
